Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(2), P. 176 - 176
Published: Jan. 30, 2024
Beyond
its
well-established
role
in
diabetes
management,
metformin
has
gained
attention
as
a
promising
therapeutic
for
inflammation-related
diseases,
largely
due
to
antioxidant
capabilities.
However,
the
mechanistic
underpinnings
of
this
effect
remain
elusive.
Using
vivo
zebrafish
models
inflammation,
we
explored
impact
on
neutrophil
recruitment
and
underlying
mechanisms
involved.
Our
data
indicate
that
reduces
histone
(H3K18)
lactylation,
leading
decreased
production
reactive
oxygen
species
(ROS)
muted
response
both
caudal
fin
injury
otic
vesicle
inflammation.
To
investigate
precise
through
which
modulates
migration
via
ROS
H3K18
meticulously
established
correlation
between
metformin-induced
suppression
lactylation
levels.
Through
supplementary
experiments
involving
restoration
lactate
ROS,
our
findings
demonstrated
elevated
levels
significantly
promoted
inflammatory
zebrafish.
Collectively,
study
illuminates
previously
unexplored
avenues
metformin's
anti-inflammatory
actions
downregulation
production,
highlighting
crucial
epigenetic
regulation
inflammation
pointing
potential
treating
inflammation-associated
conditions.
Theranostics,
Journal Year:
2025,
Volume and Issue:
15(6), P. 2338 - 2359
Published: Jan. 13, 2025
Rationale:
Tumor
cells
possess
sophisticated
strategies
to
circumvent
immune
detection,
including
the
modulation
of
endogenous
checkpoints,
particularly
those
within
B7
family.
Elucidating
mechanisms
that
govern
induction
family
molecules
is
crucial
for
advancement
immunotherapy.
Lysine
lactylation
(Kla),
a
newly
identified
epigenetic
modification,
suggested
may
play
role
in
reshaping
tumor
microenvironment
and
facilitating
evasion.
Methods:
We
analyzed
glycolysis
pathway's
enrichment
patients
with
immune-evading
tumors
assessed
impact
lactate
treatment
on
antitumor
immunity
CD8+
T
microenvironment.
interrupted
using
dehydrogenase
A
(LDHA)
knockdown
sodium
oxamate,
evaluated
its
effects
cell
cytotoxicity.
Additionally,
we
investigated
correlation
between
B7-H3
expression
pathway,
explored
molecular
underlying
lactate-induced
expression.
Results:
Our
findings
revealed
pathway
was
highly
enriched
tumors.
Lactate
inhibited
cells,
whereas
interruption
via
LDHA
or
oxamate
augmented
cytotoxicity
effectively
counteracting
found
be
closely
linked
pathway.
Mechanistically,
lactate-upregulated
H3K18la
directly
bound
promoter
conjunction
transcription
factor
Creb1
co-activator
Ep300,
leading
increased
contributing
progression
by
compromising
proportion
tumor-infiltrating
cells.
In
mouse
bearing
models,
inhibiting
suppressed
growth,
activated
demonstrated
potent
anti-tumor
efficacy.
Furthermore,
this
approach
enhanced
efficacy
anti-PD-1
treatment.
Conclusions:
This
study
uncovers
novel
mechanism
which
modulates
through
expression,
providing
new
avenues
metabolism-targeted
Journal of Experimental & Clinical Cancer Research,
Journal Year:
2023,
Volume and Issue:
42(1)
Published: March 10, 2023
Metabolic
reprogramming
is
one
of
the
hallmarks
cancer.
As
nutrients
are
scarce
in
tumor
microenvironment
(TME),
cells
adopt
multiple
metabolic
adaptations
to
meet
their
growth
requirements.
not
only
present
cells,
but
exosomal
cargos
mediates
intercellular
communication
between
and
non-tumor
TME,
inducing
remodeling
create
an
outpost
microvascular
enrichment
immune
escape.
Here,
we
highlight
composition
characteristics
meanwhile
summarize
components
corresponding
sorting
mode.
Functionally,
these
cargos-mediated
improves
"soil"
for
metastasis.
Moreover,
discuss
abnormal
metabolism
targeted
by
its
potential
antitumor
therapy.
In
conclusion,
this
review
updates
current
role
TME
enriches
future
application
scenarios
exosomes.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Oct. 27, 2023
As
a
major
product
of
glycolysis
and
vital
signaling
molecule,
many
studies
have
reported
the
key
role
lactate
in
tumor
progression
cell
fate
determination.
Lactylation
is
newly
discovered
post-translational
modification
induced
by
lactate.
On
one
hand,
lactylation
introduced
new
era
metabolism
microenvironment
(TME),
on
other
it
provided
breakthrough
point
for
elucidation
interaction
between
metabolic
reprogramming
epigenetic
modification.
Studies
shown
that
cells,
stem
cells
tumor-infiltrating
immune
TME
can
participate
development
cancer
through
downstream
transcriptional
regulation,
potential
promising
treatment
target.
This
review
summarized
discovery
effects
lactylation,
as
well
recent
research
histone
regulating
reshaping
TME.
We
also
focused
strategies
to
enhance
anti-tumor
via
targeting
lactylation.
Finally,
we
discussed
limitations
existing
proposed
perspectives
future
order
further
explore
targets.
It
may
provide
way
direction
improve
prognosis.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: May 8, 2024
Lactic
acid
was
formerly
regarded
as
a
byproduct
of
metabolism.
However,
extensive
investigations
into
the
intricacies
cancer
development
have
revealed
its
significant
contributions
to
tumor
growth,
migration,
and
invasion.
Post-translational
modifications
involving
lactate
been
widely
observed
in
histone
non-histone
proteins,
these
play
crucial
role
regulating
gene
expression
by
covalently
attaching
lactoyl
groups
lysine
residues
proteins.
This
discovery
has
greatly
enhanced
our
comprehension
lactic
acid's
involvement
disease
pathogenesis.
In
this
article,
we
provide
comprehensive
review
intricate
relationship
between
immunity,
occurrence
lactylation
malignant
tumors,
exploitation
targeted
lactate-lactylation
immunotherapy.
Additionally,
discuss
future
research
directions,
aiming
offer
novel
insights
that
could
inform
investigation,
diagnosis,
treatment
related
diseases.
Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
15
Published: May 8, 2024
Objective
The
established
link
between
posttranslational
modifications
of
histone
and
non-histone
lysine
(K)
residues
in
cell
metabolism,
their
role
cancer
progression,
is
well-documented.
However,
the
lactylation
expression
signature
triple-negative
breast
(TNBC)
remains
underexplored.
Methods
We
conducted
a
comprehensive
lactylproteome
profiling
eight
pairs
TNBC
samples
matched
adjacent
tissues.
This
was
achieved
through
4-Dimensional
label-free
quantitative
proteomics
combined
with
analysis
(4D-LFQP-LA).
identified
lactylated
proteins
detected
using
immunoblotting
immunohistochemistry
(IHC)
specific
primary
antibodies,
clinicopathological
prognostic
significance
evaluated.
Results
Our
58
sites
on
48
proteins,
delineating
protein
alteration
TNBC.
Bioinformatic
functional
analyses
indicated
that
these
play
crucial
roles
regulating
key
biological
processes
Notably,
at
position
12
(H4K12lac)
H4
domain
found
to
be
upregulated
Further
investigations
showed
high
prevalence
H4K12lac
upregulation
TNBC,
positive
rates
93.19%
(137/147)
92.93%
(92/99)
tissue
chip
validation
cohorts,
respectively.
correlated
positively
Ki-67
inversely
overall
survival
(OS)
(HR
[hazard
ratio]
=2.813,
95%CI
[credibility
interval]:
1.242-6.371,
P
=0.0164),
suggesting
its
potential
as
an
independent
marker
(HR=3.477,
95%CI:
1.324-9.130,
=0.011).
Conclusions
Lactylation
significant
post-translational
modification
proteins.
emerges
promising
biomarker
for
offering
insights
into
profiles
linking
clinical
implications
Journal of Clinical Investigation,
Journal Year:
2024,
Volume and Issue:
134(22)
Published: Nov. 14, 2024
Glioblastoma
(GBM),
an
aggressive
brain
malignancy
with
a
cellular
hierarchy
dominated
by
GBM
stem
cells
(GSCs),
evades
antitumor
immunity
through
mechanisms
that
remain
incompletely
understood.
Like
most
cancers,
GBMs
undergo
metabolic
reprogramming
toward
glycolysis
to
generate
lactate.
Here,
we
show
lactate
production
patient-derived
GSCs
and
microglia/macrophages
induces
tumor
cell
epigenetic
histone
lactylation,
activating
modification
leads
immunosuppressive
transcriptional
programs
suppression
of
phagocytosis
via
upregulation
CD47,
"don't
eat
me"
signal,
in
cells.
Leveraging
these
findings,
pharmacologic
targeting
augments
efficacy
anti-CD47
therapy.
Mechanistically,
lactylated
interacts
the
heterochromatin
component
chromobox
protein
homolog
3
(CBX3).
Although
CBX3
does
not
possess
direct
lactyltransferase
activity,
binds
acetyltransferase
(HAT)
EP300
induce
increased
substrate
specificity
lactyl-CoA
shift
cytokine
profile.
Targeting
inhibits
growth
both
cell–intrinsic
phagocytosis.
Collectively,
results
suggest
mediates
metabolism-induced
contributes
CD47-dependent
immune
evasion,
which
can
be
leveraged
augment
immuno-oncology
therapies.
Frontiers in Genetics,
Journal Year:
2024,
Volume and Issue:
15
Published: March 19, 2024
Background:
Prostate
cancer
(PCa)
is
one
of
the
most
common
malignancies
in
men
with
a
poor
prognosis.
It
therefore
great
clinical
importance
to
find
reliable
prognostic
indicators
for
PCa.
Many
studies
have
revealed
pivotal
role
protein
lactylation
tumor
development
and
progression.
This
research
aims
analyze
effect
lactylation-related
genes
on
PCa
Methods:
By
downloading
mRNA-Seq
data
TCGA
PCa,
we
obtained
differential
related
Five
machine
learning
algorithms
were
used
screen
key
then
five
overlapping
construct
survival
model
by
lasso
cox
regression
analysis.
Furthermore,
relationships
between
pathways,
mutation
immune
cell
subpopulations,
drug
sensitivity
explored.
Moreover,
two
risk
groups
established
according
score
calculated
(LRGs).
Subsequently,
nomogram
scoring
system
was
predict
disease-free
(DFS)
patients
combining
clinicopathological
features
scores.
In
addition,
mRNA
expression
levels
verified
lines
qPCR.
Results:
We
identified
5
LRGs
(ALDOA,
DDX39A,
H2AX,
KIF2C,
RACGAP1)
constructed
model.
The
AUC
values
1
-,
3
5-year
DFS
dataset
0.762,
0.745,
0.709,
respectively.
found
better
predictor
than
traditional
A
that
combined
variables
accurately
predicted
outcome
patients.
high-risk
group
higher
proportion
regulatory
T
cells
M2
macrophage,
burden,
worse
prognosis
those
low-risk
group.
had
lower
IC50
certain
chemotherapeutic
drugs,
such
as
Docetaxel,
Paclitaxel
be
highly
expressed
castration-resistant
cells.
Conclusion:
can
effectively
therapeutic
responses
Biological reviews/Biological reviews of the Cambridge Philosophical Society,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 16, 2024
ABSTRACT
In
recent
years,
a
significant
breakthrough
has
emerged
in
biology,
the
identification
of
lactylation,
novel
post‐translational
process.
This
intriguing
modification
is
not
limited
to
specific
class
proteins
but
occurs
across
diverse
range,
including
histones,
signalling
molecules,
enzymes,
and
substrates.
It
can
exert
broad
regulatory
role
various
diseases,
ranging
from
developmental
anomalies
neurodegenerative
disorders
inflammation
cancer.
Thus,
it
presents
exciting
opportunities
for
exploring
innovative
treatment
approaches.
As
result,
there
been
surge
research
interest,
leading
deeper
understanding
molecular
mechanisms
functions
underlying
lactylation
within
physiological
pathological
processes.
Here,
we
review
detection
biological
disease
effects,
providing
systematic
overview
this
modification.